Nephrocare Healt

  • Market Cap: N/A
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
702.10
5.95 (0.85%)
BSENSE

Aug 11

BSE+NSE Vol: 32.51 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationUpcoming Result: Nephrocare Healt will declare its result soon on 11 Aug 2026
stock-summaryPrice Point
High/Low

1Day

694.35710.50

52 Week

0.000.00
Valuation
Technical
Day's Volume

CASH

32.51 k (54.04%) Volume

Shareholding (Jun 2026)

FII

8.78%

Held by 17 FIIs

DII

9.05%

Held by 14 DIIs

Promoter

63.85%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Positive results in Mar 26

  • NET SALES(Q) Highest at Rs 164.33 cr
  • OPERATING PROFIT TO INTEREST(Q) Highest at 17.39 times
  • PAT(Q) Highest at Rs 10.89 cr.
2

With ROE of 6.9, it has a Very Expensive valuation with a 5.6 Price to Book Value

 
3

Increasing Participation by Institutional Investors

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 6,898 Cr ()

stock-summary
P/E

88.00

stock-summary
Industry P/E

69

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

6.18

Revenue and Profits:
Net Sales:
266 Cr
(Quarterly Results - Mar 2026)
Net Profit:
30 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
23.49%
0%
23.49%
6 Months
20.73%
0%
20.73%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Nephrocare Healt for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Nephrocare Health Services Ltd Upgraded to Hold on Improved Financial and Quality Metrics

Nephrocare Health Services Ltd Upgraded to Hold on Improved Financial and Quality Metrics

Nephrocare Health Services Ltd has been upgraded to a Hold rating with a Mojo Score of 64.0, reflecting significant improvements in its financial trend and quality parameters. The healthcare services company, operating as a small-cap stock, has demonstrated robust quarterly performance and enhanced institutional interest, despite a recent 5.55% dip in its share price. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that have driven this rating change as of 20 May 2026.

Read More
Nephrocare Health Services Ltd Quality Grade Upgrade Signals Improved Business Fundamentals

Nephrocare Health Services Ltd Quality Grade Upgrade Signals Improved Business Fundamentals

Nephrocare Health Services Ltd has seen its quality grade upgraded from "Does Not Qualify" to "Good" by MarketsMOJO, reflecting notable improvements in its business fundamentals. Despite a recent 5.55% decline in share price, the healthcare services company demonstrates strengthening operational metrics and financial discipline, positioning it as a noteworthy small-cap in the sector.

Read More
Announcements stock-summary

Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations 2015

05-Aug-2026 | Source : BSE

Please find enclosed the Trading Plans dated August 05 2026 received from Designated Persons of the company and same have been approved by the compliance officer.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

24-Jul-2026 | Source : BSE

Pursuant to Regulation 30 of the SEBI Listing Regulations we hereby inform you that the Company has scheduled an Investor Result Conference Call on Wednesday 12th August 2026 at 10:00 A.M IST to discuss the Unaudited Financial Results of the Company for the quarter ended 30th June 2026. A copy of the invitation is also attached for your information

Board Meeting Intimation for The Company Has Informed BSE That The Meeting Of The Board Of Directors Is Scheduled On 11/08/2026 Inter Alia To Consider And Approve The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter E

24-Jul-2026 | Source : BSE

Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11-08-2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

(11 Aug 2026)

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
3.39
Debt to EBITDA (avg)
0.35
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.84
Tax Ratio
20.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
17.83%
ROCE (avg)
17.70%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
88
Industry P/E
69
Price to Book Value
6.18
EV to EBIT
48.07
EV to EBITDA
28.87
EV to Capital Employed
8.51
EV to Sales
6.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.70%
ROE (Latest)
6.88%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
Bollinger Bands
Bullish
KST
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 9 Schemes (3.2%)

FIIs

Held by 17 FIIs (8.78%)

Promoter with highest holding

Edoras Investment Holdings Pte Ltd (28.3%)

Highest Public shareholder

Investcorp India Investments Holding Limited (6.29%)

Individual Investors Holdings

5.7%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 2.28% vs 3.04% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 28.88% vs 126.07% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "164.33",
          "val2": "160.66",
          "chgp": "2.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.08",
          "val2": "22.86",
          "chgp": "-3.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.27",
          "val2": "3.96",
          "chgp": "-67.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.89",
          "val2": "8.45",
          "chgp": "28.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.44%",
          "val2": "14.23%",
          "chgp": "-0.79%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Nephrocare Healt"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Nephrocare Healt"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "629.74",
          "val2": "543.60",
          "chgp": "15.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "88.16",
          "val2": "94.89",
          "chgp": "-7.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "49.76",
          "val2": "14.30",
          "chgp": "247.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-8.06",
          "val2": "34.24",
          "chgp": "-123.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.00%",
          "val2": "17.46%",
          "chgp": "-3.46%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary
Mar'26
Dec'25
Change(%)
Net Sales
164.33
160.66
2.28%
Operating Profit (PBDIT) excl Other Income
22.08
22.86
-3.41%
Interest
1.27
3.96
-67.93%
Exceptional Items
0.00
0.00
Standalone Net Profit
10.89
8.45
28.88%
Operating Profit Margin (Excl OI)
13.44%
14.23%
-0.79%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 2.28% vs 3.04% in Dec 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 28.88% vs 126.07% in Dec 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
629.74
543.60
15.85%
Operating Profit (PBDIT) excl Other Income
88.16
94.89
-7.09%
Interest
49.76
14.30
247.97%
Exceptional Items
0.00
0.00
Standalone Net Profit
-8.06
34.24
-123.54%
Operating Profit Margin (Excl OI)
14.00%
17.46%
-3.46%
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Resultsstock-summary
stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."